Last reviewed · How we verify
anaesthetics: sevofluorane
At a glance
| Generic name | anaesthetics: sevofluorane |
|---|---|
| Sponsor | University of Roma La Sapienza |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Impact of Anesthetics on FLIP (NA)
- Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis (PHASE4)
- Effectivity Gas Extraction to Prevent Anesthesiologists Waste Gas Exposure of Sevofluorane During Pediatric Induction
- Tolerance to Sevoflurane in Children Undergoing Repeated Drug Exposure
- Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies (NA)
- Anesthetics in Rhytidoplasty - A Comparison Study (NA)
- Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor (NA)
- Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- anaesthetics: sevofluorane CI brief — competitive landscape report
- anaesthetics: sevofluorane updates RSS · CI watch RSS
- University of Roma La Sapienza portfolio CI